Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Durability of S-RBD IgG Antibody Levels after Sinovac Vaccination in Healthcare Workers

Folia Medica Indonesiana · Vol. 58 No. 3 (2022) · pp. 234–241

DOI
10.20473/fmi.v58i3.35873
ISSN
2355-8393, 2599-056X
Published
2022-09-05
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

Highlights: The effectiveness of vaccination through the kinetics of the antibody response to the SARS-COV-2 vaccine administration by examining IgG S-RBD levels was aimed. Two doses of the Sinovac vaccine formed antibodies in healthy individuals in the first 3rd month after vaccination. An S-RBD IgG antibody in the 6th-month post-vaccination was significantly different between groups without a history and groups with a history of infection with COVID-19. Abstract: Since it was declared a pandemic in early 2020, Coronavirus Disease 2019 (Covid-19) has caused high morbidity and mortality in the world. In view of the urgency of the situation, vaccination efforts are needed to break the chain of disease transmission. Various types of vaccines have been successfully developed and obtained approval for emergency use. However, the effectiveness of these vaccines, both in the short and long term, has not been fully known. This study aimed to examine the effectiveness of vaccination through the kinetics of the antibody response to the administration of the SARS-COV-2 vaccine by examining IgG S-RBD levels. This study was an observational analytic study with a prospective cohort approach carried out between January and November 2021 at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Fifty health workers who received Sinovac vaccination in as many as 2 doses underwent venous blood taking and measurement of quantitative S-RBD antibody level. Then, quantitative S-RBD IgG antibody levels were measured and recorded in each subject. The mean S-RBD IgG antibody was found to have fluctuation. The titer was found to significantly increase on day 14 and dropped significantly in month 3 (p <0.001). There was a significant difference in S-RBD IgG levels 6 months after vaccination between Covid-19 uninfected groups and Covid-19 infected groups (p <0.001). In a conclusion, two doses of the Sinovac vaccine formed antibodies, although humoral immunity obtained tended to decrease in 3rd month after vaccination to healthy individuals. The average level of S-RBD IgG antibody in the sixth month post-vaccination was found to be significantly different between groups without history and groups with a history of with infection COVID-19.

Keywords

Collaboration network of the authors

40 authors · 168 co-authorship links · 85 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Universitas Katolik Widya Mandala Surabaya
  • Universitas Gadjah Mada
  • University of Würzburg
  • Rumah Sakit Dokter Soetomo
  • University of Surabaya
  • National Brain Centre
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Muhammad AminuddinRumah Sakit Dokter Soetomo2
Paulus Budiono NotopuroUniversitas Airlangga2
Abdul Hafid BajamalUniversitas Airlangga2
Valentinus BesinUniversity of Surabaya2
Mohammad Hasan MachfoedUniversitas Airlangga2
Anita BudiartiUniversitas Airlangga1
Agung Dwi Wahyu WUniversitas Airlangga1
Budi PrasetyoUniversitas Airlangga1
Arie UtarianiUniversitas Airlangga1
Indro HandojoAffiliation unknown1
Eddy SoewandojoAffiliation unknown1
Hery PriyantoAffiliation unknown1
SP EdijantoAffiliation unknown1
Trinandika ArdhanaAffiliation unknown1
Fouzal AswadAffiliation unknown1
Yetti HernaningsihUniversitas Airlangga1
Hans Kristian NugrahaUniversitas Airlangga1
Dwi Aris Agung NugrahaningsihUniversitas Gadjah Mada1
Caroline CarolineUniversitas Katolik Widya Mandala Surabaya1
Hevi WihadmadyatamiUniversitas Gadjah Mada1
Dwi Liliek KusindartaUniversitas Gadjah Mada1
Srikanth KarnatiUniversity of Würzburg1
Yudy TjahjonoUniversitas Katolik Widya Mandala Surabaya1
Hendy WijayaUniversitas Katolik Widya Mandala Surabaya1
Kuncoro FoeUniversitas Katolik Widya Mandala Surabaya1
Süleyman ErgünUniversity of Würzburg1
Nico JafetUniversitas Katolik Widya Mandala Surabaya1
Oryza ChrisantiaUniversitas Katolik Widya Mandala Surabaya1
I Made Andika Bara KusumaUniversitas Katolik Widya Mandala Surabaya1
Wuryanto HadinugrohoUniversitas Katolik Widya Mandala Surabaya1
Yufita Ratnasari WiliantoUniversitas Katolik Widya Mandala Surabaya1
Senny Yesery EsarUniversitas Katolik Widya Mandala Surabaya1
Hari Basuki NotobrotoUniversitas Airlangga1
Rahajuningsih S DharmaRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Cynthia CynthiaUniversitas Airlangga1
Muhammad HamdanUniversitas Airlangga1
Silvia Francina LumempouwNational Brain Centre1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Durability of S-RBD IgG Antibody Levels after Sinovac Vaccination in Healthcare Workers</dc:title><dc:creator>Jusak Nugraha</dc:creator><dc:creator>Cynthia Ayu Permatasari</dc:creator><dc:creator>Munawaroh Fitriah</dc:creator><dc:subject>Sinovac vaccine</dc:subject><dc:subject>COVID-19 vaccines</dc:subject><dc:subject>SARS-CoV-2</dc:subject><dc:subject>spike protein receptor-binding domain</dc:subject><dc:subject>IgG levels</dc:subject><dc:subject>antibody kinetics</dc:subject><dc:subject>humoral immunity</dc:subject><dc:subject>vaccine durability</dc:subject><dc:subject>healthcare workers</dc:subject><dc:subject>prior COVID-19 infection</dc:subject><dc:subject>vaccine effectiveness</dc:subject><dc:description xml:lang="en">Highlights: The effectiveness of vaccination through the kinetics of the antibody response to the SARS-COV-2 vaccine administration by examining IgG S-RBD levels was aimed. Two doses of the Sinovac vaccine formed antibodies in healthy individuals in the first 3rd month after vaccination. An S-RBD IgG antibody in the 6th-month post-vaccination was significantly different between groups without a history and groups with a history of infection with COVID-19. Abstract: Since it was declared a pandemic in early 2020, Coronavirus Disease 2019 (Covid-19) has caused high morbidity and mortality in the world. In view of the urgency of the situation, vaccination efforts are needed to break the chain of disease transmission. Various types of vaccines have been successfully developed and obtained approval for emergency use. However, the effectiveness of these vaccines, both in the short and long term, has not been fully known. This study aimed to examine the effectiveness of vaccination through the kinetics of the antibody response to the administration of the SARS-COV-2 vaccine by examining IgG S-RBD levels. This study was an observational analytic study with a prospective cohort approach carried out between January and November 2021 at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Fifty health workers who received Sinovac vaccination in as many as 2 doses underwent venous blood taking and measurement of quantitative S-RBD antibody level. Then, quantitative S-RBD IgG antibody levels were measured and recorded in each subject. The mean S-RBD IgG antibody was found to have fluctuation. The titer was found to significantly increase on day 14 and dropped significantly in month 3 (p &lt;0.001). There was a significant difference in S-RBD IgG levels 6 months after vaccination between Covid-19 uninfected groups and Covid-19 infected groups (p &lt;0.001). In a conclusion, two doses of the Sinovac vaccine formed antibodies, although humoral immunity obtained tended to decrease in 3rd month after vaccination to healthy individuals. The average level of S-RBD IgG antibody in the sixth month post-vaccination was found to be significantly different between groups without history and groups with a history of with infection COVID-19.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2022-09-05</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://doi.org/10.20473/fmi.v58i3.35873</dc:identifier><dc:identifier>10.20473/fmi.v58i3.35873</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 58 No 3 (2022); 234-241</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>